GNOM · Global X Genomics & Biotechnology ETF ETF
GLOBAL X FUNDS
$64.26
-1.09%
At close · Sep 4
Net assets $55,791,483
Holdings47
1 month
+10.46%
Year to date
+41.51%
52-week range
$36.00–$68.00
30-session avg volume
25,894
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000062676
- Report date
- May 31, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| GUARDANT HEALTH, INC. | GH | $3,120,212 | 5.59% |
| ILLUMINA, INC. | ILMN | $2,690,796 | 4.82% |
| NATERA, INC. | NTRA | $2,316,347 | 4.15% |
| BIOMARIN PHARMACEUTICAL INC. | BMRN | $2,279,684 | 4.09% |
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | $2,271,077 | 4.07% |
| Legend Biotech Corp | LEGN | $2,256,969 | 4.05% |
| Praxis Precision Medicines Inc | PRAX | $2,235,608 | 4.01% |
| Twist Bioscience Corp | TWST | $2,212,528 | 3.97% |
| VERTEX PHARMACEUTICALS INCORPORATED | VRTX | $2,203,239 | 3.95% |
| CRISPR Therapeutics AG | CRSP | $2,145,570 | 3.85% |
| Veracyte Inc | VCYT | $2,030,016 | 3.64% |
| Qiagen N.V. | QGEN | $1,972,530 | 3.54% |
| BioNTech SE | BNTX | $1,903,744 | 3.41% |
| BIO-TECHNE CORPORATION | TECH | $1,900,945 | 3.41% |
| MODERNA, INC. | MRNA | $1,828,848 | 3.28% |
| 10X Genomics Inc | TXG | $1,802,038 | 3.23% |
| Beam Therapeutics Inc | BEAM | $1,722,437 | 3.09% |
| ELI LILLY AND COMPANY | LLY | $1,291,745 | 2.32% |
| Ultragenyx Pharmaceutical Inc | RARE | $1,255,078 | 2.25% |
| CARIS LIFE SCIENCES, INC. | CAI | $1,132,747 | 2.03% |
| GILEAD SCIENCES, INC. | GILD | $1,089,824 | 1.95% |
| SAREPTA THERAPEUTICS, INC. | SRPT | $1,003,097 | 1.80% |
| Uniqure NV | QURE | $889,794 | 1.59% |
| INTELLIA THERAPEUTICS, INC. | NTLA | $888,295 | 1.59% |
| Stoke Therapeutics Inc | STOK | $810,831 | 1.45% |
| GeneDx Holdings Corp | WGS | $752,919 | 1.35% |
| DANAHER CORPORATION | DHR | $652,680 | 1.17% |
| BRISTOL-MYERS SQUIBB COMPANY | BMY | $644,590 | 1.16% |
| Vir Biotechnology Inc | VIR | $619,146 | 1.11% |
| CAREDX, INC. | CDNA | $587,273 | 1.05% |
| WAVE Life Sciences Ltd | WVE | $574,164 | 1.03% |
| Personalis Inc | PSNL | $438,615 | 0.79% |
| Maravai LifeSciences Holdings Inc | MRVI | $282,288 | 0.51% |
| BRUKER CORPORATION | BRKR | $238,858 | 0.43% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACB | $225,638 | 0.40% |
| Benitec Biopharma Inc | BNTC | $212,126 | 0.38% |
| AGILENT TECHNOLOGIES, INC. | A | $210,478 | 0.38% |
| FULGENT GENETICS, INC. | FLGT | $200,084 | 0.36% |
| STANDARD BIOTOOLS INC. | LAB | $196,404 | 0.35% |
| MYRIAD GENETICS, INC. | MYGN | $194,375 | 0.35% |
| EDITAS MEDICINE, INC. | EDIT | $189,349 | 0.34% |
| Prime Medicine, Inc | PRME | $188,544 | 0.34% |
| Regenxbio Inc | RGNX | $181,475 | 0.33% |
| ROCKET PHARMACEUTICALS, INC. | RCKT | $176,860 | 0.32% |
| MESA LABORATORIES, INC. | MLAB | $162,110 | 0.29% |
| Caribou Biosciences Inc | CRBU | $160,914 | 0.29% |
| QUEST DIAGNOSTICS INCORPORATED | DGX | $153,776 | 0.28% |